24 Utility of tumor-informed molecular residual disease assays in patients with complete response to immune checkpoint blockade
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |